Friberg Gregory R
Friberg Gregory R, EVP, CR, DO, reported a transaction classified as withholding at BIOMARIN PHARMACEUTICAL INC involving 4086.000000 shares for an estimated $245160.00. Reported holdings after the transaction were 47732.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 30, 2026
- Filing date
- Oct 01, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
BMRN price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- withholding Code F
- Identifier
- 0001628280-26-064272 Common Stock
- Transaction date
- Sep 30, 2026 Filed Oct 01, 2026, 08:23 PM · 1d delay
- Shares
- 4,086 sh $60.00 per share
- Estimated value
- -$245k Computed from shares × price
- Holdings after
- 47,732 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-12 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction. - tax_withholding-22 points
transaction_code = F
Tax withholding on vesting shares is mechanical.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
EVP, Chief R&D Officer
No footnotes recorded.
Original filing · 0001628280-26-0642720 other transactions
0 recent txs